95 related articles for article (PubMed ID: 7486211)
1. Endothelium-derived vasoactive substances in Bartter's syndrome.
Calò L; Cantaro S; Calabrò A; Piarulli F; Rizzolo M; Favaro S; Antonello A; Crepaldi G; Borsatti A
Angiology; 1995 Oct; 46(10):905-13. PubMed ID: 7486211
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary NO2-/NO3- and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity.
Caló L; D'Angelo A; Cantaro S; Bordin MC; Favaro S; Antonello A; Borsatti A
Am J Kidney Dis; 1996 Jun; 27(6):784-9. PubMed ID: 8651241
[TBL] [Abstract][Full Text] [Related]
3. Endothelin and vascular reactivity in Bartter's syndrome.
Calò L; Cantaro S; Rizzolo M; Favaro S; Antonello A; Borsatti A
Nephron; 1994; 66(3):370-1. PubMed ID: 8190199
[No Abstract] [Full Text] [Related]
4. Intracellular calcium signalling and vascular reactivity in Bartter's syndrome.
Calò L; D'Angelo A; Cantaro S; Rizzolo M; Favaro S; Antonello A; Borsatti A
Nephron; 1996; 72(4):570-3. PubMed ID: 8730423
[TBL] [Abstract][Full Text] [Related]
5. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.
Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A
J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive peptides in Bartter's syndrome.
Stahl MM; Vaara I; Hedner P; Ekman R
Eur J Clin Invest; 1993 Feb; 23(2):80-3. PubMed ID: 8462624
[TBL] [Abstract][Full Text] [Related]
8. Normal prostaglandinuria E2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome.
Lüthy C; Bettinelli A; Iselin S; Metta MG; Basilico E; Oetliker OH; Bianchetti MG
Am J Kidney Dis; 1995 Jun; 25(6):824-8. PubMed ID: 7771477
[TBL] [Abstract][Full Text] [Related]
9. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
Hornych A
Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
[TBL] [Abstract][Full Text] [Related]
10. Low urinary calcium excretion in Bartter's syndrome.
Rudin A; Aurell M; Wilske J
Scand J Urol Nephrol; 1988; 22(1):35-9. PubMed ID: 3387909
[TBL] [Abstract][Full Text] [Related]
11. Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome.
Di Virgilio F; Calò L; Cantaro S; Favaro S; Piccoli A; Borsatti A
Clin Sci (Lond); 1987 Apr; 72(4):483-8. PubMed ID: 3829597
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
[TBL] [Abstract][Full Text] [Related]
13. Urinary kallikrein excretion in Bartter's syndrome.
Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
[TBL] [Abstract][Full Text] [Related]
14. [Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)].
Nivet H; Rolland JC; Lebranchu Y; Dray F; Benatre A; Drucker J; Grenier B; Bagros P
Nouv Presse Med; 1980 Apr; 9(18):1287-90. PubMed ID: 6990383
[TBL] [Abstract][Full Text] [Related]
15. The role of prostaglandins in Bartter's syndrome.
Winterborn MH; Hewitt GJ; Mitchell MD
Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
[TBL] [Abstract][Full Text] [Related]
16. [The Gitelman syndrome--a differential diagnosis of Bartter syndrome].
Zimmermann J; Reincke M; Schramm L; Harlos J; Allolio B
Med Klin (Munich); 1994 Dec; 89(12):640-4. PubMed ID: 7869998
[TBL] [Abstract][Full Text] [Related]
17. Renal tubular reabsorption of chloride in Bartter's syndrome and other conditions with hypokalemia.
Rodriguez Portales JA; Delea CS
Clin Nephrol; 1986 Dec; 26(6):269-72. PubMed ID: 3802593
[TBL] [Abstract][Full Text] [Related]
18. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease.
Punzi L; Calò L; Schiavon F; Pianon M; Rosada M; Todesco S
Rev Rhum Engl Ed; 1998 Oct; 65(10):571-4. PubMed ID: 9809361
[TBL] [Abstract][Full Text] [Related]
19. Correction of hypokalemia corrects the abnormalities in erythrocyte sodium transport in Bartter's syndrome.
Korff JM; Siebens AW; Gill JR
J Clin Invest; 1984 Nov; 74(5):1724-9. PubMed ID: 6501567
[TBL] [Abstract][Full Text] [Related]
20. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.
Watanabe S; Fukumoto S; Chang H; Takeuchi Y; Hasegawa Y; Okazaki R; Chikatsu N; Fujita T
Lancet; 2002 Aug; 360(9334):692-4. PubMed ID: 12241879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
